CG
Carmignac Gestion’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79M | Buy |
101,326
+3,414
| +3% | +$2.66M | 1.22% | 26 |
|
|
2025
Q1 | $80.9M | Sell |
97,912
-53,558
| -35% | -$44.2M | 1.33% | 25 |
|
|
2024
Q4 | $117M | Buy |
151,470
+14,519
| +11% | +$11.2M | 1.86% | 17 |
|
|
2024
Q3 | $121M | Buy |
136,951
+22,558
| +20% | +$20M | 2.03% | 17 |
|
|
2024
Q2 | $104M | Sell |
114,393
-288,811
| -72% | -$261M | 1.78% | 15 |
|
|
2024
Q1 | $314M | Sell |
403,204
-405,994
| -50% | -$316M | 4.96% | 6 |
|
|
2023
Q4 | $472M | Sell |
809,198
-75,754
| -9% | -$44.2M | 7.92% | 1 |
|
|
2023
Q3 | $475M | Sell |
884,952
-68,070
| -7% | -$36.6M | 8.73% | 1 |
|
|
2023
Q2 | $447M | Buy |
953,022
+80,579
| +9% | +$37.8M | 7.7% | 1 |
|
|
2023
Q1 | $300M | Buy |
872,443
+250,413
| +40% | +$86M | 4.99% | 3 |
|
|
2022
Q4 | $228M | Sell |
622,030
-81,702
| -12% | -$29.9M | 4.11% | 7 |
|
|
2022
Q3 | $228M | Sell |
703,732
-85,006
| -11% | -$27.5M | 4.89% | 4 |
|
|
2022
Q2 | $256M | Buy |
788,738
+11,496
| +1% | +$3.73M | 5.41% | 3 |
|
|
2022
Q1 | $223M | Buy |
777,242
+464,204
| +148% | +$133M | 3.6% | 11 |
|
|
2021
Q4 | $86.5M | Buy |
+313,038
| New | +$86.5M | 1.21% | 23 |
|
|
2019
Q4 | – | Sell |
-1,008,978
| Closed | -$113M | – | 131 |
|
|
2019
Q3 | $113M | Buy |
+1,008,978
| New | +$113M | 1.42% | 29 |
|